These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16799238)

  • 1. Prediction of mortality by high-sensitivity C-reactive protein and brain natriuretic peptide in patients with dilated cardiomyopathy.
    Ishikawa C; Tsutamoto T; Fujii M; Sakai H; Tanaka T; Horie M
    Circ J; 2006 Jul; 70(7):857-63. PubMed ID: 16799238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort study.
    Li X; Chen C; Gan F; Wang Y; Ding L; Hua W
    BMC Cardiovasc Disord; 2014 May; 14():67. PubMed ID: 24885051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure.
    Fujimoto N; Onishi K; Sato A; Terasaki F; Tsukada B; Nozato T; Yamada T; Imanaka-Yoshida K; Yoshida T; Ito M; Hiroe M
    J Card Fail; 2009 Dec; 15(10):898-905. PubMed ID: 19944367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart-type fatty acid binding protein is a novel prognostic marker in patients with non-ischaemic dilated cardiomyopathy.
    Komamura K; Sasaki T; Hanatani A; Kim J; Hashimura K; Ishida Y; Ohkaru Y; Asayama K; Tanaka T; Ogai A; Nakatani T; Kitamura S; Kangawa K; Miyatake K; Kitakaze M
    Heart; 2006 May; 92(5):615-8. PubMed ID: 16387818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of high-sensitivity cardiac troponin T in patients with nonischemic dilated cardiomyopathy.
    Kawahara C; Tsutamoto T; Nishiyama K; Yamaji M; Sakai H; Fujii M; Yamamoto T; Horie M
    Circ J; 2011; 75(3):656-61. PubMed ID: 21178288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic role of brain natriuretic peptides in hemodialysis patients.
    Naganuma T; Sugimura K; Wada S; Yasumoto R; Sugimura T; Masuda C; Uchida J; Nakatani T
    Am J Nephrol; 2002; 22(5-6):437-44. PubMed ID: 12381941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.
    Yoshimura M; Yasue H; Okumura K; Ogawa H; Jougasaki M; Mukoyama M; Nakao K; Imura H
    Circulation; 1993 Feb; 87(2):464-9. PubMed ID: 8425293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M; Inomata T; Takehana H; Naruke T; Yanagisawa T; Moriguchi M; Takeda S; Izumi T
    J Am Coll Cardiol; 2008 Jun; 51(24):2329-35. PubMed ID: 18549918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death.
    Scirica BM; Cannon CP; Sabatine MS; Jarolim P; Sloane S; Rifai N; Braunwald E; Morrow DA;
    Clin Chem; 2009 Feb; 55(2):265-73. PubMed ID: 19074516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population.
    Vickery S; Webb MC; Price CP; John RI; Abbas NA; Lamb EJ
    Nephrol Dial Transplant; 2008 Nov; 23(11):3546-53. PubMed ID: 18562472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triiodothyronine and brain natriuretic peptide: similar long-term prognostic values for chronic heart failure.
    Kozdag G; Ertas G; Kilic T; Acar E; Sahin T; Ural D
    Tex Heart Inst J; 2010; 37(5):538-46. PubMed ID: 20978564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic value of plasma brain natriuretic peptide and C-reactive protein in patients with acute coronary syndromes underwent percutaneous coronary intervention].
    He B; Ding S; Pu J; Liu JP; Song W; Du YP; Shen JY; Jin SX; Sun Y; Shen L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):349-52. PubMed ID: 16776932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between indoxyl sulfate and cardiac dysfunction and prognosis in patients with dilated cardiomyopathy.
    Shimazu S; Hirashiki A; Okumura T; Yamada T; Okamoto R; Shinoda N; Takeshita K; Kondo T; Niwa T; Murohara T
    Circ J; 2013; 77(2):390-6. PubMed ID: 23100090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of tissue Doppler right ventricular systolic and diastolic function indexes combined with plasma B-type natriuretic Peptide in patients with advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Bistola V; Parissis JT; Paraskevaidis I; Panou F; Nikolaou M; Ikonomidis I; Flessas N; Filippatos G; Iliodromitis E; Kremastinos DT
    Am J Cardiol; 2010 Jan; 105(2):249-54. PubMed ID: 20102927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome.
    Mjelva ØR; Pönitz V; Brügger-Andersen T; Grundt H; Staines H; Nilsen DW
    Eur J Prev Cardiol; 2016 Jul; 23(11):1130-40. PubMed ID: 26635361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
    Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological variation of brain natriuretic peptide and cardiac events in stable outpatients with nonischemic chronic heart failure.
    Nishiyama K; Tsutamoto T; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
    Circ J; 2011; 75(2):341-7. PubMed ID: 21178290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of high-sensitivity C-reactive protein in patients with chronic heart failure.
    Xue C; Feng Y; Wo J; Li Y
    N Z Med J; 2006 Nov; 119(1245):U2314. PubMed ID: 17146489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurements of baseline and follow-up concentrations of cardiac troponin-T and brain natriuretic peptide in patients with heart failure from various etiologies.
    Taniguchi R; Sato Y; Nishio Y; Kimura T; Kita T
    Heart Vessels; 2006 Nov; 21(6):344-9. PubMed ID: 17143708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.